Skip to main content
. 2014 May 8;10(8):2387–2394. doi: 10.4161/hv.29094

Table 5. Reactgenicity of patients with hematological malignancy.

  after first
vaccination
after second
vaccination
Oculorespiratory syndrome a
  Any
  Red eyes
  Facial edema
  Respiratory symptoms
0
0
0
0
  4
2
1
3
(8)
(4)
(2)
(6)
Systematic reactions b
  Any
  Feaver (> 37 °C)
  Malaise
  Myalgia
  Headache
  Rash
1
1
0
0
0
0
(2)
(2)
12
3
8
5
8
1
(24)
(6)
(16)
(10)
(16)
(2)
Local reactions b
  Any
  Redness
  Swelling
  Induration
  Itching
  Pain
1
0
0
1
1
0
(2)
(2)
(2)
10
7
3
3
5
1
(20)
(14)
(6)
(6)
(10)
(2)

Note: Number in parentheses is expressed as percentage; asymptoms within 24 h after vaccination; bsymptoms within 48 h after vaccination.